These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 21529351)

  • 1. Inhibin secretion in women with the polycystic ovary syndrome before and after treatment with progesterone.
    Dafopoulos K; Venetis C; Messini CI; Pournaras S; Anifandis G; Garas A; Messinis IE
    Reprod Biol Endocrinol; 2011 Apr; 9():59. PubMed ID: 21529351
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibin A and inhibin B in women with polycystic ovarian syndrome during treatment with FSH to induce mono-ovulation.
    Anderson RA; Groome NP; Baird DT
    Clin Endocrinol (Oxf); 1998 May; 48(5):577-84. PubMed ID: 9666869
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mid-follicular phase pulses of inhibin B are absent in polycystic ovarian syndrome and are initiated by successful laparoscopic ovarian diathermy: a possible mechanism regulating emergence of the dominant follicle.
    Lockwood GM; Muttukrishna S; Groome NP; Matthews DR; Ledger WL
    J Clin Endocrinol Metab; 1998 May; 83(5):1730-5. PubMed ID: 9589683
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vaginal progesterone administration in physiological doses normalizes raised luteinizing hormone levels in patients with polycystic ovarian syndrome.
    Buckler HM; Bangah M; Healy DL; Burger HG
    Gynecol Endocrinol; 1992 Dec; 6(4):275-82. PubMed ID: 1492584
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum inhibin levels in polycystic ovary syndrome: basal levels and response to luteinizing hormone-releasing hormone agonist and exogenous gonadotropin administration.
    Buckler HM; McLachlan RI; MacLachlan VB; Healy DL; Burger HG
    J Clin Endocrinol Metab; 1988 Apr; 66(4):798-803. PubMed ID: 3126215
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of inhibin in women with polycystic ovary syndrome (PCOS).
    Tanabe K; Saijo A; Park JY; Kohriyama S; Sano Y; Nakamura Y; Iizuka R
    Horm Res; 1990; 33 Suppl 2():10-7. PubMed ID: 2128878
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of follicle-stimulating-hormone-stimulated dimeric inhibin and estradiol responses as indicators of granulosa cell function in polycystic ovary syndrome and normal women.
    Wachs DS; Coffler MS; Malcom PJ; Chang RJ
    J Clin Endocrinol Metab; 2006 Aug; 91(8):2920-5. PubMed ID: 16720653
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Obesity and serum luteinizing hormone level have an independent and opposite effect on the serum inhibin B level in patients with polycystic ovary syndrome.
    Cortet-Rudelli C; Pigny P; Decanter C; Leroy M; Maunoury-Lefebvre C; Thomas-Desrousseaux P; Dewailly D
    Fertil Steril; 2002 Feb; 77(2):281-7. PubMed ID: 11821084
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ovarian age-related responsiveness to human chorionic gonadotropin in women with polycystic ovary syndrome.
    Piltonen T; Koivunen R; Perheentupa A; Morin-Papunen L; Ruokonen A; Tapanainen JS
    J Clin Endocrinol Metab; 2004 Aug; 89(8):3769-75. PubMed ID: 15292303
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Do basal inhibin A and inhibin B levels have value in the diagnosis of polycystic ovary syndrome?
    Torgac M; Kokcu A; Cetinkaya MB; Alper T; Malatyalioglu E
    Gynecol Endocrinol; 2005 Jun; 20(6):322-6. PubMed ID: 16019381
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum levels of inhibins are differentially altered in patients with polycystic ovary syndrome: effects of being overweight and relevance to hyperandrogenism.
    Pigny P; Cortet-Rudelli C; Decanter C; Deroubaix D; Soudan B; Duhamel A; Dewailly D
    Fertil Steril; 2000 May; 73(5):972-7. PubMed ID: 10785223
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Age related changes in follicle stimulating hormone, luteinizing hormone, oestradiol and immunoreactive inhibin in women of reproductive age.
    MacNaughton J; Banah M; McCloud P; Hee J; Burger H
    Clin Endocrinol (Oxf); 1992 Apr; 36(4):339-45. PubMed ID: 1424166
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum anti-Müllerian hormone levels remain high until late reproductive age and decrease during metformin therapy in women with polycystic ovary syndrome.
    Piltonen T; Morin-Papunen L; Koivunen R; Perheentupa A; Ruokonen A; Tapanainen JS
    Hum Reprod; 2005 Jul; 20(7):1820-6. PubMed ID: 15802325
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-Müllerian Hormone and Inhibin-A, but not Inhibin-B or Insulin-Like Peptide-3, may be Used as Surrogates in the Diagnosis of Polycystic Ovary Syndrome in Adolescents: Preliminary Results.
    Yetim A; Yetim Ç; Baş F; Erol OB; Çığ G; Uçar A; Darendeliler F
    J Clin Res Pediatr Endocrinol; 2016 Sep; 8(3):288-97. PubMed ID: 27125339
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High serum concentration of total inhibin in polycystic ovary syndrome.
    Tsigkou A; Luisi S; De Leo V; Patton L; Gambineri A; Reis FM; Pasquali R; Petraglia F
    Fertil Steril; 2008 Nov; 90(5):1859-63. PubMed ID: 18423626
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aberrantly increased mRNA expression of betaglycan, an inhibin co-receptor in the ovarian tissues in women with polycystic ovary syndrome.
    Zhu R; Zhou X; Chen Y; Qiu C; Xu W; Shen Z
    J Obstet Gynaecol Res; 2010 Feb; 36(1):138-46. PubMed ID: 20178540
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibin secretion by the sheep ovary during the luteal and follicular phases of the oestrous cycle and following stimulation with FSH.
    Tsonis CG; McNeilly AS; Baird DT
    J Endocrinol; 1988 May; 117(2):283-91. PubMed ID: 3132526
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dynamics of bioactive follicle-stimulating hormone secretion in women with polycystic ovary syndrome: effects of estradiol and progesterone.
    Padmanabhan V; Christman GM; Randolph JF; Kelch RP; Marshall JC; Beitins IZ
    Fertil Steril; 2001 May; 75(5):881-8. PubMed ID: 11334898
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased androgen response to follicle-stimulating hormone administration in women with polycystic ovary syndrome.
    Wachs DS; Coffler MS; Malcom PJ; Shimasaki S; Chang RJ
    J Clin Endocrinol Metab; 2008 May; 93(5):1827-33. PubMed ID: 18285408
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum inhibin B in polycystic ovary syndrome: regulation by insulin and luteinizing hormone.
    Welt CK; Taylor AE; Martin KA; Hall JE
    J Clin Endocrinol Metab; 2002 Dec; 87(12):5559-65. PubMed ID: 12466353
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.